Xenon Pharmaceuticals
Stock Forecast, Prediction & Price Target

Xenon Pharmaceuticals (XENE) stock Price Target by analysts

Last Year
Average Price Target

$51.5

Potential upside: 37.84%

Based on 2 analysts

Xenon Pharmaceuticals price prediction

Strike.market

What is Xenon Pharmaceuticals stock analysts` prediction?

Xenon Pharmaceuticals stock forecast: Based on 2 Wall Street analysts` predicted price targets for Xenon Pharmaceuticals in the last 3 months, the avarage price target is $51.5, with a high forecast of $NaN. The average price target represents a 37.84% change from the last price of $37.36.

Disclaimer: This is not investment advice. Don't use price targets as the only investment indicator. Always remember to do your own thorough research and due diligence before making an investment decision.

Xenon Pharmaceuticals stock Price Target by analysts

Full breakdown of analysts given Xenon Pharmaceuticals price targets

Analyst name & company
Analyst win rate
Publish date
Price target
Price when posted
Source Historical targets
Danielle Brill
Raymond James
0%
0/2
11 months ago $50 33.83% upside $39.42 TheFly
Previous targets (1)
Douglas Tsao
H.C. Wainwright
0%
0/1
11 months ago $53 41.86% upside $39.37 TheFly
Previous targets (0)
Laura Chico
Wedbush
0%
0/1
about 1 year ago $49 31.15% upside $41.05 TheFly
Previous targets (0)
Brian Abrahams
RBC Capital
0%
0/1
about 1 year ago $55 47.21% upside $36.25 StreetInsider
Previous targets (0)
Unknown
Goldman Sachs
N/A
over 2 years ago $60 60.59% upside $39.57 Benzinga
N/A
Unknown
Wells Fargo
N/A
almost 3 years ago $50 33.83% upside $35.86 Benzinga
N/A
Unknown
Guggenheim
N/A
almost 3 years ago $49 31.15% upside $35 Benzinga
N/A
Danielle Brill
Raymond James
0%
0/2
almost 3 years ago $52 39.18% upside $35.52 TheFly
Previous targets (1)
Unknown
Leerink Partners
N/A
about 3 years ago $46 23.12% upside $39.68 Benzinga
N/A
Unknown
RBC Capital
N/A
about 3 years ago $46 23.12% upside $40.53 Benzinga
N/A
Unknown
Wedbush
N/A
about 3 years ago $41 9.74% upside $30.85 Benzinga
N/A
Unknown
RBC Capital
N/A
over 3 years ago $41 9.74% upside $27.07 Benzinga
N/A

Xenon Pharmaceuticals Financial Estimates

Xenon Pharmaceuticals Revenue Estimates

Xenon Pharmaceuticals EBITDA Estimates

Xenon Pharmaceuticals Earnings per Share Estimates

Passed Analyst forecast
Metric 12/31/2021 12/31/2022 12/31/2023 12/31/2025 12/31/2026 12/31/2027 12/31/2028
Revenue
 
% change YoY
$18.43M
 
N/A
$9.43M
 
-48.83%
$0
 
-100%
Avg: $9.38M
Low: $9.38M
High: $9.38M
avg. 0%
Avg: $60.58M
Low: $60.58M
High: $60.58M
avg. 545.30%
Avg: $366.81M
Low: $366.81M
High: $366.81M
avg. 505.45%
Avg: $646.66M
Low: $646.66M
High: $646.66M
avg. 76.29%
Net Income
 
% change YoY
$-78.88M
 
N/A
$-125.37M
 
-58.93%
$-182.39M
 
-45.48%
Avg: $-268.68M
Low: $-282.94M
High: $-68.22M
avg. -47.31%
Avg: $-305.88M
Low: $-311.70M
High: $-107.69M
avg. -13.84%
Avg: $-59.36M
Low: $-59.36M
High: $-59.36M
avg. 80.59%
Avg: $96.06M
Low: $96.06M
High: $96.06M
avg. 261.83%
EBITDA
 
% change YoY
$-78.99M
 
N/A
$-129.14M
 
-63.48%
$-210.51M
 
-63.00%
Avg: $-5.58M
Low: $-5.58M
High: $-5.58M
avg. 97.34%
Avg: $-36.02M
Low: $-36.02M
High: $-36.02M
avg. -545.30%
Avg: $-218.11M
Low: $-218.11M
High: $-218.11M
avg. -505.45%
Avg: $-384.52M
Low: $-384.52M
High: $-384.52M
avg. -76.29%
EPS
 
% change YoY
-$1.81
 
N/A
-$2.07
 
-14.36%
-$2.73
 
-31.88%
Avg: -$3.2
Low: -$4.23
High: -$1.02
avg. -17.10%
Avg: -$3.39
Low: -$4.66
High: -$1.61
avg. -6.06%
Avg: -$0.89
Low: -$0.89
High: -$0.89
avg. 73.82%
Avg: $1.44
Low: $1.44
High: $1.44
avg. 261.83%
Operating Expenses
 
% change YoY
$97.43M
 
N/A
$138.57M
 
42.23%
$46.54M
 
-66.41%
Avg: $14.37M
Low: $14.37M
High: $14.37M
avg. -69.12%
Avg: $92.73M
Low: $92.73M
High: $92.73M
avg. 545.30%
Avg: $561.49M
Low: $561.49M
High: $561.49M
avg. 505.45%
Avg: $989.87M
Low: $989.87M
High: $989.87M
avg. 76.29%

FAQ

What is Xenon Pharmaceuticals stock earnings growth forecast?

Wall Street analysts estimate the annual average earnings growth rate of 70.31% in 2025-2028.

We have gathered data from 13 analysts. Their low estimate is -282.94M, average is -268.68M and high is -68.22M.

What is Xenon Pharmaceuticals stock revenue growth forecast?

Wall Street analysts forecast annual average revenue growth of 281.76% in 2025-2028.

We have gathered data from 10 analysts. Their low revenue estimate is $9.38M, average is $9.38M and high is $9.38M.

What is Xenon Pharmaceuticals stock earnings per share growth forecast?

Wall Street analysts forecast annual average earnings growth of 78.12% in 2025-2028.

We have gathered data from 13 analysts. Their low earnings per share estimate is -$4.23, average is -$3.2 and high is $-1.02.

What is the best performing analyst?

In the last twelve months 2 analysts have been covering Xenon Pharmaceuticals stock. The most successful analyst is Danielle Brill.